A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...

Radiation therapy is a standard treatment option, especially for those with localized prostate cancer. However, the side ...

Although September is known as Prostate Cancer Awareness Month, I have chosen to tell my prostate journey for Movember, Men’s ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

“Prostate cancer patients with life expectancies of less than five or 10 years were being subjected to treatments that can ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...

Routt County resident James Onufrak knew his dad was diagnosed with prostate cancer at age 61, so he worked with his own ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...

Listen to a short summary Read by Guy R. Your browser does not support the audio element.Talking about "cancer" can make ...

Evidence suggests that combining metformin with standard of care could increase survival and offer other benefits to patients with high-volume disease.

ANDROGEN deprivation therapy (ADT) has been the cornerstone of treatment for advanced castration-sensitive prostate cancer ...